Los Angeles Capital Management LLC Foghorn Therapeutics Inc. Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 15,851 shares of FHTX stock, worth $75,292. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,851Holding current value
$75,292% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FHTX
# of Institutions
88Shares Held
35.4MCall Options Held
8.7KPut Options Held
2.4K-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$60.2 Million20.03% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$25.2 Million1.57% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.03MShares$14.4 Million0.52% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$10.9 Million0.01% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL2.03MShares$9.64 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $198M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...